user-icon
Position
CEO and President
Company
Eyevensys
Location
Paris FRANCE
Bio

Patricia Zilliox, joined Eyevensys as President and CEO as of October 2017. She had already joined Eyevensys Board of Directors since May 2016.

Patricia has more than 25 years of global clinical development expertise. She previously served as Chief Drug Development Officer of the Clinical Research Institute, a division of the Foundation Fighting Blindness, in Columbia, MD, USA. From late 2008 until May 2011, Dr. Zilliox was head of clinical development at Alcon Laboratories, managing clinical development programs in areas of eye diseases such as glaucoma, allergy, dry eye, infectious diseases of the eye, and retinal diseases such as dry- and wet-AMD. Dr. Zilliox previously worked for Alcon in Paris, France, where she was responsible for the execution of Alcon’s European ophthalmology clinical trials.